Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Mecobalamin

Generic Name: Mecobalamin

Drug Type: Small Molecule

Chemical Formula: C_₆₃H_₉₁CoN_₁₃O_₁₄P

CAS Number: 13422-55-4

Unique Ingredient Identifier: BR1SN1JS2W

Overview

Not Available

Background

Not Available

Indication

Not Available

Associated Conditions

Vitamin B12 Deficiency

Clinical Trials

Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling

Phase 2

Not yet recruiting

Posted: 2025/02/06

Sponsor:

Hejiang Ye

ID:NCT06813274

Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury

Phase 4

Not yet recruiting

Posted: 2024/01/24

Sponsor:

Sichuan Provincial P...

ID:NCT06220929

Effect of Ultrasound-guided Stellate Ganglion Block Combined With Facial Nerve and Glossopharyngeal Nerve Block on the Treatment of Sudden Deafness

Not Applicable

Recruiting

Posted: 2022/11/21

Sponsor:

Zhuan Zhang

ID:NCT05623384

Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients

Phase 4

Posted: 2022/01/11

Sponsor:

Xiangya Hospital of ...

ID:NCT05184049

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Phase 3

Active, not recruiting

Posted: 2021/12/21

Sponsor:Sun Yat-Sen Memorial...

ID:NCT05165069

FDA Approved Products

Lipovite

Manufacturer:Perdido Key Health and Wellness Inc

Route:INTRAMUSCULAR

Strength:1 mg in 1 mL

Approved: 2015/11/23

NDC:70104-128

Livita Adults

Manufacturer:PureTek Corporation

Route:ORAL

Strength:2.4 ug in 1 mL

Approved: 2023/12/18

NDC:59088-659

Davimet-M

Manufacturer:PureTek Corporation

Route:ORAL

Strength:4.5 ug in 1 1

Approved: 2023/11/30

NDC:59088-158

Folinex

Manufacturer:Vivera Pharmaceuticals, Inc.

Route:ORAL

Strength:1 mg in 1 1

Approved: 2020/02/10

NDC:72380-916

Methylcobalamin

Manufacturer:Perdido Key Health and Wellness Inc

Route:INTRAMUSCULAR

Strength:1 mg in 1 mL

Approved: 2015/11/20

NDC:70104-826

Singapore Approved Products

METHYCOBAL INJECTION 500 mcg/ml

Manufacturer:Nipro Pharma Corporation Ise Plant

Form:INJECTION

Strength:500 mcg/ml

Online:Yes

Approved: 1991/07/03

Approval:SIN06349P

METHYCOBAL TABLET 500 mcg

Manufacturer:BUSHU PHARMACEUTICALS LTD.

Form:TABLET, SUGAR COATED

Strength:500 mcg

Online:Yes

Approved: 1991/06/20

Approval:SIN06291P

MECONEURO CAPSULES 500 MCG

Manufacturer:PT. Novell Pharmaceutical Laboratories

Form:CAPSULE

Strength:500 mcg

Online:Yes

Approved: 2023/03/08

Approval:SIN16735P

NEUROMETHYN CAP. 500 mcg

Manufacturer:SAM CHUN DANG PHARM CO LTD

Form:CAPSULE

Strength:500 mcg

Online:Yes

Approved: 1999/05/05

Approval:SIN10917P

Related News

NPPA Sets Retail Prices for 84 Drugs Including Empagliflozin Combinations Following Patent Expiry

15 days ago

India's National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 84 new drug formulations, including 36 combinations containing the recently off-patent diabetes medication empagliflozin.

HEALEY ALS Platform Trial: Streamlining Drug Development for Amyotrophic Lateral Sclerosis

6 months ago

The HEALEY ALS Platform Trial is pioneering a new approach to accelerate the development of effective treatments for amyotrophic lateral sclerosis (ALS).

New Drug Development Pipeline Shows Promise for ALS Treatment with 53 Candidates Under Investigation

2 years ago

A comprehensive review of ALS drug development reveals 53 new drug candidates in clinical trials between 2020-2022, with 13 compounds advancing to Phase 3 trials and showing promising therapeutic potential.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy